272 related articles for article (PubMed ID: 9499069)
21. The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus.
Asghar N; Lee YP; Nilsson E; Lindqvist R; Melik W; Kröger A; Överby AK; Johansson M
Sci Rep; 2016 Dec; 6():39265. PubMed ID: 27982069
[TBL] [Abstract][Full Text] [Related]
22. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.
Kofler RM; Leitner A; O'Riordain G; Heinz FX; Mandl CW
J Virol; 2003 Jan; 77(1):443-51. PubMed ID: 12477849
[TBL] [Abstract][Full Text] [Related]
24. The relationship between the flaviviruses Skalica and Langat as revealed by monoclonal antibodies, peptide mapping and RNA sequence analysis.
Guirakhoo F; Heinz FX; Mandl CW; Holzmann H; Kunz C; Gresíková M
J Gen Virol; 1991 Feb; 72 ( Pt 2)():333-8. PubMed ID: 1847173
[TBL] [Abstract][Full Text] [Related]
25. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
26. A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice.
Rumyantsev AA; Murphy BR; Pletnev AG
J Virol; 2006 Feb; 80(3):1427-39. PubMed ID: 16415020
[TBL] [Abstract][Full Text] [Related]
27. Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses.
Mandl CW; Heinz FX; Stöckl E; Kunz C
Virology; 1989 Nov; 173(1):291-301. PubMed ID: 2554575
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of the tick-borne encephalitis virus cyclization elements indicates major differences between mosquito-borne and tick-borne flaviviruses.
Kofler RM; Hoenninger VM; Thurner C; Mandl CW
J Virol; 2006 Apr; 80(8):4099-113. PubMed ID: 16571826
[TBL] [Abstract][Full Text] [Related]
29. Virulence of tick-borne encephalitis virus is associated with intact conformational viral RNA structures in the variable region of the 3'-UTR.
Sakai M; Muto M; Hirano M; Kariwa H; Yoshii K
Virus Res; 2015 May; 203():36-40. PubMed ID: 25801453
[TBL] [Abstract][Full Text] [Related]
30. The degree of attenuation of tick-borne encephalitis virus depends on the cumulative effects of point mutations.
Gritsun TS; Desai A; Gould EA
J Gen Virol; 2001 Jul; 82(Pt 7):1667-1675. PubMed ID: 11413378
[TBL] [Abstract][Full Text] [Related]
31. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness.
Goto A; Hayasaka D; Yoshii K; Mizutani T; Kariwa H; Takashima I
Vaccine; 2003 Sep; 21(25-26):4043-51. PubMed ID: 12922141
[TBL] [Abstract][Full Text] [Related]
32. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
Pletnev AG; Bray M; Lai CJ
J Virol; 1993 Aug; 67(8):4956-63. PubMed ID: 8331735
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype.
Heiss BL; Maximova OA; Thach DC; Speicher JM; Pletnev AG
J Virol; 2012 May; 86(10):5647-59. PubMed ID: 22419812
[TBL] [Abstract][Full Text] [Related]
34. Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs.
Gritsun TS; Venugopal K; Zanotto PM; Mikhailov MV; Sall AA; Holmes EC; Polkinghorne I; Frolova TV; Pogodina VV; Lashkevich VA; Gould EA
Virus Res; 1997 May; 49(1):27-39. PubMed ID: 9178494
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding.
de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X
PLoS Pathog; 2015 Mar; 11(3):e1004738. PubMed ID: 25734338
[TBL] [Abstract][Full Text] [Related]
36. The molecular biology of tick-borne encephalitis virus. Review article.
Heinz FX; Mandl CW
APMIS; 1993 Oct; 101(10):735-45. PubMed ID: 8267950
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
Pletnev AG; Men R
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
[TBL] [Abstract][Full Text] [Related]
38. Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses.
Mandl CW; Holzmann H; Kunz C; Heinz FX
Virology; 1993 May; 194(1):173-84. PubMed ID: 8097605
[TBL] [Abstract][Full Text] [Related]
39. Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR.
Gritsun TS; Gould EA
Virology; 1995 Dec; 214(2):611-8. PubMed ID: 8553563
[TBL] [Abstract][Full Text] [Related]
40. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
